Glucose Lowering Therapeutic Strategies for Type 2 Diabetic Patients with Chronic Kidney Disease in Primary Care Setting in France: A Cross-Sectional Study

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left"> </td><td align="center" colspan="3">
									Treatment with contraindicated or not recommended drugs</td></tr><tr class="thead"><td align="left">GP satisfied with glycaemic control</td><td align="center">Yes (%) </td><td align="center">No (%)</td><td align="center">All (%)</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">Yes (%)</td><td align="center">81 (45)</td><td align="center">44 (24)</td><td align="center">125 (69)</td></tr><tr><td align="left">No (%)</td><td align="center">33 (18)</td><td align="center">22 (12)</td><td align="center">55 (30)</td></tr><tr><td align="left" colspan="4"><hr/></td></tr><tr><td align="left">All (%)</td><td align="center">114 (63)</td><td align="center">66 (36)</td><td align="center">180 (100)</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

GP’s satisfaction with glycaemic control and its association with indication or recommendation of glucose lowering therapy in CKD patients.

International Journal of Endocrinology

tab3

Table 3

Table 3: Glucose Lowering Therapeutic Strategies for Type 2 Diabetic Patients with Chronic Kidney Disease in Primary Care Setting in France: A Cross-Sectional Study 

Table 3 | Glucose Lowering Therapeutic Strategies for Type 2 Diabetic Patients with Chronic Kidney Disease in Primary Care Setting in France: A Cross-Sectional Study 